Alex Stojanovic

Alex is Head of Strategy at TNG Creative, a lean boutique consultancy that bridges the gaps between STRATEGY + SCIENCE + CREATIVE for life-science companies and start ups. He has more than 18 years' experience in the life sciences.

He is also currently a Managing Partner at The Naissos Group, Co-Founder and CEO of Qoolo, and COO at Oncolyze. Prior to these roles, Alex served as Vice President of BD and Commercial at Phosphagenics, and Senior Director of New Product Planning at Grünenthal GmbH. Earlier in his career, Alex was a Consultant with ZS Associates.

Alex holds a PhD in Pharmacology and Toxicology from Dartmouth College. He completed a Postdoctoral Fellowship at Northwestern University and executive education at MIT Sloan.